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Giant multinucleated cells (GMCs)' were identified long ago as having a
possible role in tumor growth (1), removal of foreign particulate matter (2), and
sequestration oftubercle bacilli (3). Since that time many others have confirmed
that GMCs are associated with granulomatous lesions formed in response to
foreign bodies, viruses, and bacteria (4, 5). For example, the immune response
to tubercle bacilli results in a classic granulomatous lesion (6), which presents as
a large number ofmacrophages and GMCs surrounding an infectious focus with
a layer of lymphocytes aggregating around the circumference. Because these
lesions invariably show extensive focal recruitment of macrophages/monocytes,
it was proposed that monocytes were the precursors ofGMCs. These multinucle-
ated forms are also called Langhans' giant cells, giant foreign body cells, and
giant cells ofinflammation.
Further studies indicated that GMCs were formed as a result of cell fusion
rather than abnormal cell division (6), but the causative agent for this process
was unknown. In 1973, Galindo (7) demonstrated that GMCs could develop in
vitro from normal rabbit alveolar macrophages treated with supernatants of
Bacillus Calmette-Guerin (BCG)-sensitized lymph nodecells. These workers then
postulated that a lymphokine, termed macrophage fusion factor (MFF), was
released from sensitized T lymphocytes upon specific antigen stimulation (8).
The organization of granulomatous lesions, with their mantle of lymphocytes,
also implicates the involvement of T cell-derived lymphokines in vivo.
It is well known that activated T cells produce a diverse array of factors that
affect various macrophage activities, in addition to the formation of GMCs (8).
The T cell activitiesdescribed include inhibitionofthe migration ofmacrophages
(MIF) (9-11), aggregation of macrophages (MAagF) (12, 13), and activation of
macrophages to efficiently kill tumor cells (MAF) (14). The relationship between
MFF, MAF, MAagF, and MIF has not yet been defined. Recently, it was shown
that the mouse T cell product, IL-4, induces tumoricidal activity in cultured
macrophages (15) in a way similar to the activity previously described as MAF.
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' Abbreviations used in this paper:
￿
CSF, colony stimulating factor;G-CSF, granulocyte CSF; GMC,
giant multinucleated cell; GM-CSF, granulocyte/macrophage CSF; MAF, macrophage activation
factor; MAagF, macrophage aggregation factor; MIF, migration inhibition factor; M-CSF, macro-
phageCSF; MFF, macrophage fusion factor.
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In the present communication, we attempt to further clarify the relationship
between these various factors and IL-4 using bone marrow and alveolar cell
cultures.
Materials and Methods
Cytokines and Antibodies.
￿
Purified mouse rIL-3 (16), recombinant granulocyte colony
stimulating factor (G-CSF), and recombinant macrophage colony stimulating factor (M-
CSF) were provided by colleagues at DNAX Research Institute (Palo Alto, CA). Purified
mouse rIL-4 (17) and recombinant granulocyte/macrophage colony stimulating factor
(rGM-CSF) (18) were a gift of Schering-Plough Research (Bloomfield, NJ). 1 U of each
factor is defined as that amount that stimulates half-maximal ['H]thymidine incorporation
of an appropriate factor-dependent cell line cultured at 5 X 10' cells/ml. The anti-IL-4
mAb 111111 (19), was kindly provided by R. Coffman (DNAX Research Institute). 111111
antibodies were used at 25 ug/ml, a concentration that completely blocks the biological
activity of 500 U/ml of IL-4. Anti-mouse IFN-y mAb, XMG-1 (20), was a gift of T.
Mosmann (DNAX Research Institute). XMG-1 antibodies used at 20 ug/ml abolish the
activity of IFN-y at 78 ng/ml.
Cell Culture.
￿
Basic growth medium for all of our cell cultures consists of RPMI 1640
medium (M . A. Bioproducts, Walkersville, MD) supplemented with 50 AM 2-ME and 5-
10% FCS (Irvine Scientific, Santa Ana, CA). For soft agar cultures, varying numbers of
cellswere plated in 35-mm culture dishes (Falcon; Becton Dickinson & Co., Lincoln Park,
NJ) containing 1 ml ofbasic medium and 0.3% (wt/vol) agar or basic agar medium further
supplemented with various purified factors as indicated in individual experiments. For
liquid cultures, cells from various organs were suspended at 5 X 105/ml in basic medium
containing various combinations of growth factors as indicated. All cultures were incu-
bated at 37'C in 5% C02.
Assay For The Formation of Multinucleated Cells in Bone Marrow and Peritoneal Cell
Cultures. Bone marrow cells were harvested from the femurs ofadult CBA/J mice (The
Jackson Laboratory, Bar Harbor, ME) as previously described (21). Cells were plated at
10'/ml in two-chamber tissue culture slides (Lab-Tek, Naperville, IL) in basic medium
containing one of the hemopoietic growth factors with or without IL-4. Cultures were
incubated at 37'C in 5% C02. At various times, cultures were terminated and cytospins
of the nonadherent cells, as well as the original Lab-Tek slides, were fixed and stained
with Wright-Giemsa (Sigma Chemical Co., St. Louis, MO) for microscopic evaluation.
Multinucleated cells were enumerated and reported as percent of adherent cells present
in an average of 160 fields per slide when viewed at X 400 magnification. Multinucleated
cells are defined as cells with three or more nuclei per cell.
Nonstimulated alveolar macrophages were washed from the lungs of mice using
broncho-alveolar lavage (22). Briefly, a blunted 18-gauge needle was inserted into the
trachea of a mouse and secured with sterile thread. The lungs were washed 6 times with
1 ml volumes of cold Hank's Balanced Salt Solution (HBSS) (Gibco Laboratories, Grand
Island, NY). Cells were then plated at 1 X 105 cells/ml and assayed for GMC formation
as described for bone marrow.
Histochemical Stains. Using established histochemical methods and reagents from
Sigma Chemical Co., cells adherent to Lab-Tek chamber slides were stained with nonspe-
cific esterase, peroxidase, alkaline phosphatase, or acid phosphatase.
Autoradiography.
￿
Bone marrow cells were harvested and cultured overnight at 5 X
10' cells/ml in basic medium supplemented with IL-3 (200 U/ml). Half the cells were
then pulsed with 0.5,Ci/ml ["H]thymidine (Amersham Corp., Arlington Heights, IL) for
4 h. Labeled cells were then mixed with nonlabeled cells in various ratios and plated in
tissue culture chamber slides at 10' cells/ml with or without 250 U/ml IL-4. On day 4 of
culture, nonadherent cells were gently removed and slides were fixed in methanol for 5
min. Slides were then dipped in nuclear track emulsion (Kodak No. 165 4433) and kept
in the dark at 4 ° C for 3 d. After warming to room temperature, slides were developed in
the dark for 3 min in Kodak D-19 developer (No. 146 4593), rinsed briefly, fixed in600 INTERLEUKIN 4 INDUCES FORMATION OF MULTINUCLEATED CELLS
FIGURE 1 .
￿
Effect of IL-4 on theviability and proliferation
of bone marrow suspension cultures. Nonadherent bone
marrow cells were suspendedat 5 X 105/ml in basic medium
(0)andin basicmedium supplemented with IL-4 (200 U/ml)
(p), IL-3 (200 U/ml) (O), or IL-3 plus IL-4 (/). At various
time points, nonadherent cells were removed and the viable
cellscountedusingtrypan blue dye. Thevalues reported are
the mean t SD of triplicate cultures.
Kodak fixer (No. 197 1746) for 3 min and rinsed in distilled water before staining with
Wright-Giemsa for microscopic examination.
Results
Bone Marrow Cells Stimulated with IL-4 in Liquid Suspension Cultures Show
Inhibition of IL-3-dependent Growth and Formation of Giant Multinucleated
Cells. Nonadherent bone marrow cells were cultured in unsupplemented liquid
medium or in medium containing IL-4, IL-3, and IL-4 plus IL-3. At various time
intervals, cell viability, growth, and morphology were assessed. There was a rapid
decrease in the number of viable nonadherent cells present in unsupplemented
cultures and in IL-4-stimulated cultures (Fig. 1). The number of nonadherent
cells increased 15-fold in cultures containing IL-3 but only 3-fold in cultures
containing IL-3 plus IL-4. Further, the growth curves were different. Maximum
cell numbers were reached by day 6 when stimulated with IL-3 and by day 4
when stimulated with IL-3 and IL-4 . Wright-Giemsa staining indicated that
-80% of the cells present in cultures stimulated by IL-3 with or without IL-4
were granulocytes and macrophages at various stages of differentiation . The
other 20% consisted of undifferentiated progenitor cells and mature and imma-
ture forms of red blood cells, eosinophils and mast cells. Although IL-4 inhibited
the IL-3-dependent proliferation of hemopoietic cells, it did not inhibit cell
differentiation. This result is consistent with the ability of IL-4 to inhibit IL-3-
dependent colony formation in soft agar bone marrow cultures (23) .
Next, the bottom of each culture dish was examined by phase microscopy for
the generation of adherent cells. After 10 d of culture, there were a few scattered
patches ofadherent cells in the unsupplemented cultures and in cultures contain-
ing only IL-4. However, there was a relatively largeadherent population present
in cultures stimulated with IL-3 and IL-3 plus IL-4 . The adherent layers appeared
different in these two latter cultures. In the presence of IL-4, the adherent
monolayer was approximately fourfold less dense and it contained many large
cells with irregular borders. After staining with Wright-Giemsa, the adherent
layer stimulated by IL-3 was found to consist of a uniform population of
mononuclear cells typical of macrophages and fibroblasts (Fig. 2A). In contrast,
the adherent layer present in cultures stimulated by IL-3 plus IL-4 was composed
of both mononuclear and multinucleated cells (Fig. 2B). The multinucleatedMcINNES AND RENNICK
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FIGURE 3. Dose-response curve for IL-4 in-
duced multinucleated cell formation. Bone
marrow cells were incubated in tissue culture
chamber slides with IL-3-supplemented me-
dium and varying concentrations of IL-4. On
day 4, duplicate slides were stained with
Wright-Giemsa. A total of 160 fields per slide
(500-1,000 cells) were examined using a x 40
objective and a x 10 eyepiece. The values re-
ported are the average number of multinucle-
ated cells observed per 100 cells counted.
cells showed considerable variation with respect to size and number ofnuclei per
cell (Fig. 2, B-D). They usually formed in clusters and displayed a strong avidity
for plastic since no GMCs were observed in cytospin preparations of the non-
adherent population .
The few patches of adherent cells present in cultures containing no growth
factor or IL-4 alone were found to consist primarily of fibroblasts surrounded
by several macrophages. In the IL-4-containing cultures, an occasional multinu-
cleated cell was associated with these cell clusters . No multinucleated cells were
found in unsupplemented cultures. Thus, it appears that IL-4 is necessary to
induce the formation of multinucleated cells. However, the high frequency of
GMCs found only in cultures supplemented with both IL-4 and IL-3 suggests
that they derive from IL-3-dependent mononuclear cells.
Quantitation of Multinucleated Cell Formation.
￿
In the following studies, the
optimal conditions for the formation of multinuclear cells were determined.
Unless otherwise stated, these assays were performed with cell cultures supple-
mented with IL-3 at 200 U/ml to sustain the viability and proliferation of the
target population. This amount of IL-3 was found to support maximum growth
ofbone marrow cells in liquid medium or soft agar cultures. Multinucleated cells
were classified into three categories according to the number of nuclei per cell
(i.e., 3-5, 6-10, and >10). We found that the frequency ofmultinucleated cells
ofall sizes was optimal usingIL-4 at 100 U/ml or more, although a small response
was seen at concentrations as low as 20 U/ml (Fig. 3). Control cultures failed to
yield >0.8% multinucleated cells of the smallest category (3-5 nuclei/cell), and
no giant multinucleated cells (>10 nuclei/cell) were documented.
The time course for the formation of multinucleated cells from bone marrow
cultures optimally stimulated with IL-4 (250 U/ml) plus IL-3 (200 U/ml)is shown
in Fig. 4. Multinucleated cells in all three categories were first noted on day 2 of
culture and reached maximum numbers by day 5. Giant multinucleated cellsc
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FIGURE 4.
￿
Time courseof IL-4-induced multinucleated
cell formation. Bone marrow cells were cultured in me-
dium containing IL-3 (200 U/ml)andan optimal concen-
tration of IL-4 (250 U/ml). Duplicate cultures were ter-
minated at the time points indicated and stained slides
were scored as described in Fig. 2 legend. The values
reported are the average number of multinucleated cells
observed ner 100cells counted
with over 50 nuclei (Fig. 2C) were more frequent after prolonged incubation
(4-5 d).
Cell Fusion Is Required for the Formation of Giant Multinucleated Cells.
￿
Other
investigators (8, 24) have shown that the formation ofmultinucleated cells, after
stimulation of cell cultures with lymphocyte conditioned medium, is dependent
on cell fusion. Our observation that IL-4 has an inhibitory effect on the factor-
dependent proliferation ofcultured bone marrow cells (Fig. 1) raised the possi-
bility that IL-4 may induce the formation of multinucleated cells by interfering
with normal cell division. To discern between asynchronous cell division and cell
fusion, we performed the following autoradiographic study. Bone marrow cells
were incubated in IL-3 overnight to stimulate proliferation and increase the
number of cells that would incorporate radiolabeled nucleotides. Nonadherent
cells, which contained the majority ofactively dividing cells, were harvested and
divided into duplicate cultures. One culture was pulsed with 0.5 ACi/ml [3H]-
thymidine for 4 h, which resulted in 32% of the cells incorporating label without
loss of cell viability or growth. Aliquots of these cells were then mixed with the
unlabeled cells in ratios of 3:1, 1:1, and 1:3. Cultures consisting entirely of
radiolabeled cells or ofvarious cell mixtures were incubated for 4 d in IL-3 plus
IL-4, and then prepared for autoradiography. The highest number of radiola-
beled nuclei per GMC was found in cultures consisting entirely of labeled cells.
Furthermore, the numberofradiolabeled nuclei per GMC consistently decreased
as we decreased the ratio of labeled to unlabeled cells from 3:1 (Fig. 5A) to 1:3
(Fig. 5B). This finding is consistent with cell fusion rather than asynchronous
division where the nuclei within a given cell would be all unlabeled or all labeled
but with a lower specific activity. With asynchronous division, only the ratio of
labeled to unlabeled GMCs, not the ratio of radiolabeled nuclei per cell, would
change to reflect the portion of labeled precursors used to initiate the cultures.604 INTERLEUKIN 4 INDUCES FORMATION OF MULTINUCLEATED CELLS
FIGURE 5 .
￿
Photomicrographs of Wright-Giemsa-stained GMCs after autoradiography . Pic-
tures show the frequency of radiolabeled nuclei per GMCs present in cultures prepared by
mixing ['H]thymidine-labeled and nonlabeled bone marrow cells in a 3 :1 ratio (A) and a 1 :3
ratio (B). Radiolabeled nuclei are covered by silver grains . Unlabeled nuclei are evident by
their weak staining with hematoxylin . Binucleated cell with one labeled and one nonlabeled
nuclei is shown in C (A, B, and C : x 1088) .McINNES AND RENNICK
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FIGURE 6.
￿
The formation of multinu-
cleated cells is completely blocked by
anti-IL-4 antibody but not by anti-IFN-
.y antibody . Bone marrow cells were cul-
tured at 10 5 cells/ml in basic medium
supplemented with IL-3 (200 U/ml)and
IL-4 (200 U/ml) . Anti-IL-4 antibody at
25 ag/ml was added to IL-4 containing
cultures on days 0, 2, and 3 . An isotype
matched anti-TNP antibody (25 rug/ml)
and an anti-IFN-'Y antibody (20 Wg/ml)
were added to separate IL-4-treated cul-
tures on day 0 . Duplicate cultures were
scored on day5 andthe values reported
are the average number of multinucle-
ated cells observed per 100 cells
counted .
We also found a substantial number of binucleated cells with one heavily labeled
and one unlabeled nucleus (Fig . 5C), an unlikely outcome of nuclear division .
IL-4 Appears to Directly Mediate the Formation of Multinucleated Cells . To
determine whether the fusion ofmononuclear cells was the result of a direct or
an indirect effect of IL-4, anti-IL-4 antibodies were added to bone marrow
cultures at various times after their initiation in medium containing IL-3 and IL-
4 . As expected, the formation of multinucleated cells was completely blocked by
IL-4-specific antibodies added on day 0 of culture (Fig. 6) . An isotype-matched
anti-TNP antibody used at the same concentration had no effect . When anti-IL-
4 antibodies wereadded on day 2 or 3, after multinucleated cells begin to appear,
the total number of GMCs produced by day 5 was reduced to levels similar to
that found on day 2 or 3 in kinetic experiments (Fig. 3) . Moreover, there was a
complete absence of cells with >10 nuclei, demonstrating that optimal formation
ofGMCs requires constant stimulation by IL-4 . These results indicate that IL-4
directly mediates cell fusion rather than inducing the production of a fusion
factor in the first 2-3 d of culture whose activity would be unaffected by the
delayed addition of anti-IL-4 antibodies . This conclusion was further supported
by the finding that IL-4-specific antibodies completely neutralized the ability of
conditioned media from 5-d-old cultures containing GMCs to induce fusion of
fresh bone marrow cells (data not shown) .
It has been reported that IFN-y can induce the fusion of human peripheral
blood monocytes (25) . To verify that mouse IFN-y was not involved in the fusion
of IL-4-treated cells, anti-IFN-y antibodies were added to bone marrow cells on
day 0 of culture . We found that these antibodies had no significant effect on the
development ofGMCs in the presence of IL-4 (Fig. 6) .
MacrophagesAppear to be the Precursors of IL-4-induced GMCs.
￿
Previous work
has suggested that macrophages give rise to GMCs (6, 7) . Our results agree with
these studies . First, GMCs were present in cultures stimulated with IL-4 in
combination with M-CSF or GM-CSF but not with IL-4 plus G-CSF (data not
shown) . Similar to the results obtained with IL-3, none of these hemopoietic
growth factors alone induced the formation of GMCs . Thus, IL-4 can elicit the606 INTERLEUKIN 4 INDUCES FORMATION OF MULTINUCLEATED CELLS
production of multinucleated cells but only when used as a costimulant with
growth factors that efficiently sustain the growth and viability of macrophages.
Second, all multinucleated cells were positive for nonspecific esterase and acid
phosphatase but were negative for peroxidase and alkaline phosphatase, as is
characteristic of macrophages. Finally, we assessed the effects of IL-4 on cells
obtained by broncho-alveolar lavage. The majority of these cells (>90%) were
macrophages asjudged by morphological and staining characteristics. The gen-
eration of GMCs with time was evaluated using culture conditions described
above. In the presence ofIL-4, the kinetics ofGMC formation was equivalent to
that observed with heterogenous bone marrow cell cultures (data not shown).
IL-4 Promotes Aggregation and Inhibits Migration of Bone Marrow Macro-
phages. Bone marrow cells at 5 x 104 were seeded into soft agar cultures
containing M-CSF with and without IL-4. After 7-10 d of incubation, macro-
phage colonies stimulated by M-CSF had a smooth appearance with cells migrat-
ing into the surrounding agar (Fig. 7A) . In contrast, cells within macrophage
colonies stimulated by M-CSF plus IL-4 became clumped and failed to migrate
(Fig. 7B).
Discussion
A granuloma is a localized inflammatory immune response. While the role of
the granuloma is to contain and eradicate foreign agents, the physiological
relevance of giant multinucleated cells within this lesion is unclear. Early in the
immune response, a large number of granulocytes and macrophages appear in
the injured tissue. Apparently, most of these cells are recruited from the bone
marrow (26, 27), although some cells are derived from the proliferation oflocal
precursors (28). The number oflymphocytes detected in thearea is much smaller
and the mechanism by which they home to the specific site is unknown. Subse-
quent immobilization, maturation and activation of the inflammatory cells are
essential to the efficient containment and elimination offoreign agents (29, 30).
The duration of the inflammatory response may be prolonged as in cases of
indigestible foreign bodies and infections with certain parasites or virulent
intracellular organisms. GMCs are most often associated with these chronic
granulomatous inflammations. In these cases, there is usually extensive tissue
damage followed by fibrosis which may exaggerate the pathology of the disease
(31, 32).
Using various animal models, in vivo and in vitro studies have suggested that
the initiation, maintenance, and resolution of granulomatous inflammations are
dependent on soluble T cell factors. It has been shown that sensitized T cells, as
well as granulomatous tissue infiltrated with lymphocytes, produce factors that
inhibit the migration and promote the agglutination of normal macrophages in
vitro (13, 22, 29, 33). These activities would account for the compact appearance
of granulomas. Furthermore, T cell-derived factors enhance the phagocytic,
bactericidal, and tumoricidalproperties ofmacrophages, activities (34-36),which
have been linked to an effective granulomatous response. Another indication for
T cell products is the finding that in some granulomas, antibodies are synthesized
locally (29). It is envisioned that binding of immune complexes may further
activate inflammatory cellswith Fcreceptors and aidin antigen clearance. Finally,McINNES AND RENNICK
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FIGURE 7 .
￿
Photomicrographs of macrophage colonies formed in the presence and absence
of IL-4 . Bone marrow cells were cultured at 10 5 cells/ml in soft agar cultures supplemented
with M-CSF (200 U/ml) without (A)and with (B) IL-4 (100 U/ml) . Pictures show the general
appearance of the colonies between 7 and 10 d ofculture .
it has been shown that T cell derived factor(s) induce the fusion of macrophages
to form giant multinucleated cells (8) . Because multinucleated macrophages are
not functionally superior to mononuclear cells (37-42), their proposed role as a
last attempt to sequester persisting agents (38) seems likely but lacks formal
documentation .
Evidence for the role of T cell-derived factors in the granulomatous response608 INTERLEUKIN 4 INDUCES FORMATION OF MULTINUCLEATED CELLS
has been largely by inference. At present, most lymphokines that mediate certain
aspects of the response are chemically undefined. The data presented herein
clearly demonstrate that purified rIL-4 directly stimulates multinucleated cell
formation via the fusion of CSF-dependent bone marrow and alveolar macro-
phages. Our results also show that IL-4 is capable of inducing their aggregation
and inhibiting their migration. These activities, previously ascribed to separate
factors termed MFF, MAagF, and MIF, provide compelling evidence for IL-4 as
one of the mediators of a classic granulomatous response. However, other
lymphokines may mediate similar biological activities. In human studies, IFN--y
has been shown to induce the fusion of blood monocytes (25) and exhibit MIF-
like activity (43).
Because IL-4 mediates multiple biological activites, it may account for many
ofthe cellular interactions that typify granulomas. Recently, it has been reported
that IL-4 has MAF activity (15). Moreover, it not only functions as a potent
costimulator of B cell proliferation and Ig production, but it also affects the
factor-dependent growth of other cell lineages (44). In particular, the ability of
IL-4 to enhance the growth of granulocyte progenitors in response to G-CSF
(23, 45) and macrophage progenitors in response to M-CSF (23) may be relevant
to the expansion of inflammatory cells within the granulomatous lesion. How-
ever, we have also shown that IL-4 may have antagonistic effects on the prolif-
eration ofmore immature hemopoietic progenitor cells (23). Under certain assay
conditions, IL-4 appears to directly or indirectly inhibit the stromal cell-depend-
ent growth ofearly B lineage cells and the IL-3-dependent proliferation ofearly
monopotential and multipotential myeloid progenitor cells. This raises the pos-
sibility that negative regulation by IL-4 may be instrumental in diminishing the
inflammatory response by preventing excessive expansion of the progenitor cell
pool, thus minimizing local tissue damage and fibrous repair (29). In this context,
the potential use of IL-4 and its antagonists in the clinical management of
disseminated granulomatous disease merits further study.
Summary
Giant multinucleated cells (GMCs) are associated with granulomatous lesions
that form in response to various infectiousandnoninfectious agents. The present
study shows that mouse IL-4 induces the in vitro formation ofGMCs by factor-
dependent bone marrow and alveolar monocytes via cell fusion. GMCs appear 2
d after incubation ofcell cultures with 20 U/ml or more ofIL-4. Anti-IL-4 mAbs
block theappearance of GMCs in these cultures, indicating that IL-4 acts directly
on monocytes to promote fusion and does not secondarily induce the production
of other soluble fusion factors. In soft agar cultures, IL-4 also causes the
aggregation of macrophages and diminishes their migration. The role of IL-4 in
a granulomatous inflammatory response is discussed.
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